
CBD Critical Mass is an indica-dominant, high-CBD hybrid derived from Critical Mass CBD genetics. This strain was specifically bred for therapeutic users seeking meaningful cannabinoid-driven relief with a balanced CBD:THC ratio that provides the entourage effect while minimizing overwhelming psychoactive intensity. The Critical Mass CBD parent contributes the high-CBD genetics, dense indica structure, and reliable flowering performance, while the breeding program selected for elevated CBD expression alongside moderate THC levels. The result is a cultivar that delivers clear-headed therapeutic relief with earthy-sweet-herbal aromatics, making it suitable for patients who need daytime functionality alongside symptom management. Its indica-dominant genetics provide gentle body relaxation that complements the CBD-driven therapeutic effects, and its moderate CBD:THC ratio is considered favorable for a range of therapeutic applications.
| Attribute | Value |
|---|---|
| Type | Indica-Dominant Hybrid (High-CBD) |
| THC % | 5-10% |
| CBD % | 8-15% |
| Dominant Terpenes | Caryophyllene, Humulene, Myrcene |
| Flowering Time | 45-55 days |
| Yield | Moderate to High (400-500 g/m² indoor) |
| Growing Difficulty | Easy to Moderate |
CBD Critical Mass is derived from Critical Mass CBD genetics:
Parent lineage: Critical Mass CBD x unknown
CBD Critical Mass was developed as part of the broader effort to create high-CBD cultivars for therapeutic applications. The Critical Mass lineage provides a reliable, high-yielding, easy-to-grow genetic foundation, while the CBD selection process pushes the cannabinoid ratio toward the therapeutic range. The resulting cultivar maintains the generous yields and forgiving growing characteristics of Critical Mass while delivering meaningful CBD-driven relief.
| Cannabinoid | Typical Range |
|---|---|
| THC (Total) | 5-10% |
| CBD | 8-15% |
| CBG | 0.5-1.5% |
| CBN | <0.5% (increases with age) |
The CBD:THC ratio typically falls between 1.5:1 and 3:1, which is considered favorable for many therapeutic applications. The moderated THC provides enough psychoactive character to enhance the entourage effect (the synergistic interaction between cannabinoids and terpenes) while the high CBD delivers the primary therapeutic relief. This ratio is often described as providing clear-headed symptom management with minimal cognitive impairment.
| Terpene | Approximate Share | Notes |
|---|---|---|
| Caryophyllene | 25-40% | Primary terpene; spicy, peppery with reported anti-inflammatory properties; interacts with CB2 receptors |
| Humulene | 15-25% | Significant presence; earthy, woody, hoppy with reported anti-inflammatory effects |
| Myrcene | 10-20% | Earthy, herbal base contributing to gentle body relaxation |
| Pinene | 3-8% | Subtle pine freshness adding aromatic complexity |
| Linalool | 2-5% | Floral sweetness with calming associations |
The caryophyllene-humulene-myrcene combination produces CBD Critical Mass's distinctive earthy-sweet-herbal aroma. Caryophyllene is notable as the only terpene known to directly interact with the body's endocannabinoid system (CB2 receptors), which may enhance the strain's therapeutic profile when combined with high CBD content.
CBD Critical Mass is widely reported to produce:
Onset: Effects begin within minutes when smoked or vaporized; 30-90 minutes when consumed orally.
Duration: 2-3 hours for inhaled consumption; 4-6 hours for oral consumption.
Intensity: Mild. The high CBD and low-moderate THC produce a gentle experience focused on therapeutic relief rather than intoxication.
⚠️ Effects are self-reported and vary by individual, dose, tolerance, and consumption method. Not a prediction of any individual's experience. CBD Critical Mass is bred for therapeutic use and is generally well-tolerated, but individual responses to CBD:THC ratios vary.
Not Medical Advice -- The following lists commonly reported therapeutic applications. This does not constitute medical advice. Consult a healthcare professional before using cannabis therapeutically.
Commonly reported uses include:
Commonly reported adverse effects:
| Attribute | Details |
|---|---|
| Difficulty | Easy to Moderate -- inherits the forgiving Critical Mass genetics with high-CBD breeding |
| Flowering Time | 45-55 days (indoor) -- notably short, consistent with Critical Mass lineage |
| Yield | 400-500 g/m² indoor; 500-600 g/plant outdoor -- among the higher yields for CBD cultivars |
| Plant Height | Short to medium -- compact indica-dominant structure |
| Preferred Environment | Indoor or outdoor; performs well in both. The Critical Mass genetics are known for resilience and adaptability. |
| Resistance | Good resistance to mold and pests, inherited from the robust Critical Mass genetics. The dense flower structure requires adequate airflow during late flowering. Responds well to SOG, SCROG, topping, and LST. The generous yields combined with high CBD make this one of the most commercially attractive CBD cultivars. Outdoor harvest in the Northern Hemisphere typically falls in late September. |
CBD Critical Mass is one of the easier high-CBD strains to grow, benefiting from the forgiving Critical Mass genetics. The short flowering time of 45-55 days and generous yields are significant advantages. The compact indica structure is ideal for indoor cultivation. The strain's combination of easy cultivation, high yields, and meaningful CBD content makes it attractive for both commercial and home growing. The critical factor is maintaining stable conditions to ensure optimal CBD expression throughout the flowering phase.
Back to Strain Database | Hybrid Strains | Strain Template Guide